Establishing Clinical Significance in Rotator Cuff Disease

NCT ID: NCT06677320

Last Updated: 2025-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

69 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-03

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to learn about rotator cuff patients. The main questions it aims to answer are:

* What is the minimal clinically important difference value of the Shoulder Disability Questionnaire, the short version of the Western Ontario Rotator Cuff Index, the Shoulder Rating Questionnaire, and the University of California-Los Angeles Shoulder Scale?
* What is the substantial clinical benefit value of the Shoulder Disability Questionnaire, the short version of the Western Ontario Rotator Cuff Index, the Shoulder Rating Questionnaire, and the University of California-Los Angeles Shoulder Scale?
* What is the patient-acceptable symptomatic state value of the Shoulder Disability Questionnaire, the short version of the Western Ontario Rotator Cuff Index, the Shoulder Rating Questionnaire, and the University of California-Los Angeles Shoulder Scale?
* What is the maximal outcome improvement value of the Shoulder Disability Questionnaire, the short version of the Western Ontario Rotator Cuff Index, the Shoulder Rating Questionnaire, and the University of California-Los Angeles Shoulder Scale?
* What are the risk factors that prevent rotator cuff patients from reaching the minimal clinically important difference value?
* What are the risk factors that prevent rotator cuff patients from reaching the substantial clinical benefit value?
* What are the risk factors that prevent rotator cuff patients from reaching the patient-acceptable symptomatic state value?
* What are the risk factors that prevent rotator cuff patients from reaching the maximal outcome improvement value?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rotator Cuff Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rotator cuff patients

Patients with rotator cuff disease who will receive conservative treatment.

Exercise

Intervention Type OTHER

Patients with rotator cuff disease will receive exercise treatment for two months.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise

Patients with rotator cuff disease will receive exercise treatment for two months.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* to be over 18 years old
* to be a rotator cuff patient

Exclusion Criteria

* to have another pathology in the affected shoulder area
* to have a neurological, rheumatological, or oncological disease
* to have radiculopathy
* to have had a previous fracture or operation in the affected shoulder area
* to be not cooperative enough for what will be done within the scope of the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kırklareli University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ozan Gür, PT

Research Assistant

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ozan Gür, MSc

Role: PRINCIPAL_INVESTIGATOR

Kırklareli University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kırklareli Eğitim ve Araştırma Hastanesi

Kırklareli, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ozan Gür, MSc

Role: CONTACT

506 338 38 49 ext. 90

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-1636

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.